|
業務類別
|
Medical Devices |
|
業務概覽
|
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions. |
| 公司地址
| 700 Chesapeake Drive, Redwood, CA, USA, 94063 |
| 電話號碼
| +1 650 364-0400 |
| 傳真號碼
| +1 650 364-0403 |
| 公司網頁
| https://www.pulmonx.com |
| 員工數量
| 291 |
| Mr. David A. Lehman |
General Counsel |
美元 458.60K |
08/04/2025 |
| Mr. Geoffrey Beran Rose |
Chief Commercial Officer |
-- |
08/04/2025 |
| Mr. Glendon E. French |
Director, President and Chief Executive Officer |
美元 195.56K |
27/10/2025 |
| Mr. Mehul Joshi |
Chief Financial Officer and Principal Accounting Officer |
美元 334.33K |
08/04/2025 |
|
|
| Mr. Dana G. Mead, Jr |
Non-Executive Chairman of the Board |
08/04/2025 |
| Mr. Daniel P. Florin |
Independent Director |
08/04/2025 |
| Mr. Thomas W. Burns |
Independent Director |
08/04/2025 |
| Ms. Georgia Garinois-Melenikiotou |
Independent Director |
08/04/2025 |
| Mr. Glendon E. French |
Director, President and Chief Executive Officer |
27/10/2025 |
| Mr. Richard M. Ferrari |
Independent Director |
08/04/2025 |
| Ms. Tiffany Sullivan |
Independent Director |
08/04/2025 |
|
|
|
|
